NCT04163562View on ClinicalTrials.gov

Oral Immunotherapy for Peanut Allergic Patients

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 11, 2020

Primary Completion Date

May 31, 2025

Study Completion Date

September 30, 2025

Conditions
Peanut Allergy
Interventions
DRUG

INP20

Part A: Oral INP20 administration at ascending doses once daily for 2 weeks. Part B: Two doses of oral INP20 derived from Part A once daily for 6 months.

DRUG

Placebo

Part A: Oral placebo administration onces daily for 2 weeks. Part B: Oral placebo administration onces daily for 6 months.

Trial Locations (2)

31008

RECRUITING

Clinica Universidad de Navarra, Pamplona

RECRUITING

Complejo Hospittalario de Navarra, Pamplona

All Listed Sponsors
lead

InnoUp Farma S.L.

INDUSTRY